Literature DB >> 9013975

Molecular cloning of rat C4b binding protein alpha- and beta-chains: structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins.

A Hillarp1, H Wiklund, A Thern, B Dahlbäck.   

Abstract

The C4b binding protein (C4BP) functions as a regulator of the complement system by interacting with the activated form of the fourth complement component, C4b. Human C4BP also interacts with the anticoagulant protein S and the serum amyloid P component (SAP). It is composed of seven identical 70-kDa alpha-chains and one 45-kDa beta-chain. The alpha-chain contains a binding site for C4b, whereas the beta-chain contains the protein S binding site. Recent studies have shown rabbit and bovine plasma to lack a C4BP-protein S complex, and the mouse beta-chain gene to have evolved into a pseudogene. Using a gel filtration chromatography system in combination with Western blotting, we detected a complex between C4BP and protein S in rat plasma, similar to the complex known in human plasma. Using purified rat C4BP and SAP we were unable to detect any complex between the two proteins, but rat C4BP was able to form a complex with human SAP. Rat cDNA clones encoding the C4BP alpha- and beta-chains were isolated from a rat liver cDNA library. The rat alpha-chain cDNA predicted a mature polypeptide chain of 545 amino acid residues, whereas the beta-chain cDNA predicted a mature polypeptide of 243 amino acid residues. The overall amino acid sequence identities between the rat alpha-chain and the mouse, human, rabbit, and bovine alpha-chains were 64, 60, 59, and 52%, respectively. The identities between the rat beta-chain and the human and bovine beta-chains were 68 and 57%, respectively. The rat represents the first non-primate species in which the C4BP-protein S interaction has been found to be conserved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013975

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection.

Authors:  Jutamas Ngampasutadol; Sanjay Ram; Anna M Blom; Hanna Jarva; Ann E Jerse; Egil Lien; Jon Goguen; Sunita Gulati; Peter A Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

2.  The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function.

Authors:  Y Härdig; A Hillarp; B Dahlbäck
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

3.  Epididymal C4b-binding protein is processed and degraded during transit through the duct and is not essential for fertility.

Authors:  Mayumi I Nonaka; Eva Zsigmond; Akihiko Kudo; Hayato Kawakami; Kaoru Yoshida; Manabu Yoshida; Natsuko Kawano; Kenji Miyado; Masaru Nonaka; Rick A Wetsel
Journal:  Immunobiology       Date:  2014-11-11       Impact factor: 3.144

4.  Dependence on vitamin K-dependent protein S for eukaryotic cell secretion of the beta-chain of C4b-binding protein.

Authors:  Sofia Carlsson; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

5.  The Hidden Side of Complement Regulator C4BP: Dissection and Evaluation of Its Immunomodulatory Activity.

Authors:  Inmaculada Serrano; Ana Luque; Francesca Mitjavila; Anna M Blom; Santiago Rodríguez de Córdoba; M Cristina Vega; Joan Torras; Josep M Aran
Journal:  Front Immunol       Date:  2022-04-25       Impact factor: 8.786

6.  Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes.

Authors:  Thomas P Zwaka; Dimitar Manolov; Cüneyt Ozdemir; Nikolaus Marx; Ziya Kaya; Matthias Kochs; Martin Höher; Vinzenz Hombach; Jan Torzewski
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Positive selection on human gamete-recognition genes.

Authors:  Michael W Hart; Daryn A Stover; Vanessa Guerra; Sahar V Mozaffari; Carole Ober; Carina F Mugal; Ingemar Kaj
Journal:  PeerJ       Date:  2018-01-11       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.